{"id":"https://openalex.org/W4296136972","doi":"https://doi.org/10.36691/rja1563","title":"Ceftriaxone induced fixed drug eruption in patient with common variable immunodeficiency","display_name":"Ceftriaxone induced fixed drug eruption in patient with common variable immunodeficiency","alternate_titles":[],"publication_year":2022,"publication_date":"2022-09-08","ids":{"openalex":"https://openalex.org/W4296136972","doi":"https://doi.org/10.36691/rja1563"},"language":"en","primary_location":{"id":"doi:10.36691/rja1563","doi":"https://doi.org/10.36691/rja1563","is_oa":false,"landing_page_url":"https://doi.org/10.36691/rja1563","pdf_url":null,"source":{"id":"https://openalex.org/S4210199164","display_name":"Russian Journal of Allergy","issn_l":"1810-8830","issn":["1810-8830","2686-682X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Russian Journal of Allergy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4296136972"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5097685642","display_name":"Alina S. Shubina","orcid":"https://orcid.org/0000-0003-0379-1218","observed_orcids":["https://orcid.org/0000-0003-0379-1218"]},"institutions":[{"id":"https://openalex.org/I64264942","display_name":"Federal Medical-Biological Agency","ror":"https://ror.org/052ay8m85","country_code":"RU","type":"government","lineage":["https://openalex.org/I64264942"]}],"countries":["RU"],"is_corresponding":true,"raw_author_name":"Alina S. Shubina","raw_affiliation_strings":["National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia"],"raw_orcid":"https://orcid.org/0000-0003-0379-1218","affiliations":[{"raw_affiliation_string":"National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia","institution_ids":["https://openalex.org/I64264942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003115893","display_name":"Tatiana N. Myasnikova","orcid":"https://orcid.org/0000-0001-8491-195X","observed_orcids":["https://orcid.org/0000-0001-8491-195X"]},"institutions":[{"id":"https://openalex.org/I64264942","display_name":"Federal Medical-Biological Agency","ror":"https://ror.org/052ay8m85","country_code":"RU","type":"government","lineage":["https://openalex.org/I64264942"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Tatiana N. Myasnikova","raw_affiliation_strings":["National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia"],"raw_orcid":"https://orcid.org/0000-0001-8491-195X","affiliations":[{"raw_affiliation_string":"National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia","institution_ids":["https://openalex.org/I64264942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080925279","display_name":"Evgeny A. Frolov","orcid":"https://orcid.org/0000-0002-0800-5960","observed_orcids":["https://orcid.org/0000-0002-0800-5960"]},"institutions":[{"id":"https://openalex.org/I64264942","display_name":"Federal Medical-Biological Agency","ror":"https://ror.org/052ay8m85","country_code":"RU","type":"government","lineage":["https://openalex.org/I64264942"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Evgeny A. Frolov","raw_affiliation_strings":["National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia"],"raw_orcid":"https://orcid.org/0000-0002-0800-5960","affiliations":[{"raw_affiliation_string":"National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia","institution_ids":["https://openalex.org/I64264942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103076195","display_name":"Smirnov Vv","orcid":"https://orcid.org/0000-0002-8232-6682","observed_orcids":["https://orcid.org/0000-0002-8232-6682"]},"institutions":[{"id":"https://openalex.org/I64264942","display_name":"Federal Medical-Biological Agency","ror":"https://ror.org/052ay8m85","country_code":"RU","type":"government","lineage":["https://openalex.org/I64264942"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Valery V. Smirnov","raw_affiliation_strings":["National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia"],"raw_orcid":"https://orcid.org/0000-0002-8232-6682","affiliations":[{"raw_affiliation_string":"National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia","institution_ids":["https://openalex.org/I64264942"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067523572","display_name":"Elena Alexandrovna Latysheva","orcid":"https://orcid.org/0000-0002-1606-205X","observed_orcids":["https://orcid.org/0000-0002-1606-205X"]},"institutions":[{"id":"https://openalex.org/I64264942","display_name":"Federal Medical-Biological Agency","ror":"https://ror.org/052ay8m85","country_code":"RU","type":"government","lineage":["https://openalex.org/I64264942"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Elena A. Latysheva","raw_affiliation_strings":["National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia"],"raw_orcid":"https://orcid.org/0000-0002-1606-205X","affiliations":[{"raw_affiliation_string":"National Research Center \u2015 Institute of Immunology Federal Medical-Biological Agency of Russia","institution_ids":["https://openalex.org/I64264942"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5097685642"],"corresponding_institution_ids":["https://openalex.org/I64264942"],"apc_list":null,"apc_paid":null,"fwci":0.2528,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.44835209,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"19","issue":"3","first_page":"410","last_page":"420"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10634","display_name":"Food Allergy and Anaphylaxis Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceftriaxone","display_name":"ceftriaxone","score":0.949999988079071},{"id":"https://openalex.org/keywords/fixed-drug-eruption","display_name":"fixed drug eruption","score":0.9980000257492065},{"id":"https://openalex.org/keywords/common-variable-immunodeficiency","display_name":"common variable immunodeficiency","score":0.9769999980926514},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7599999904632568},{"id":"https://openalex.org/keywords/drug-hypersensitivity","display_name":"drug hypersensitivity","score":0.7179999947547913},{"id":"https://openalex.org/keywords/cephalosporins","display_name":"cephalosporins","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cross-reactivity","display_name":"cross-reactivity","score":0.9760000109672546},{"id":"https://openalex.org/keywords/patch-testing","display_name":"patch testing","score":0.8220000267028809},{"id":"https://openalex.org/keywords/primary-immunodeficiency","display_name":"primary immunodeficiency","score":0.8119999766349792},{"id":"https://openalex.org/keywords/antibiotic-therapy","display_name":"antibiotic therapy","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8327218294143677},{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.8241111040115356},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6244786977767944},{"id":"https://openalex.org/C2776433325","wikidata":"https://www.wikidata.org/wiki/Q1472818","display_name":"Common variable immunodeficiency","level":3,"score":0.6059005856513977},{"id":"https://openalex.org/C2779060952","wikidata":"https://www.wikidata.org/wiki/Q2068896","display_name":"Drug allergy","level":3,"score":0.5236325263977051},{"id":"https://openalex.org/C2779515644","wikidata":"https://www.wikidata.org/wiki/Q718675","display_name":"Drug eruption","level":3,"score":0.5147793292999268},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.5066578984260559},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.47752299904823303},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.46454715728759766},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.46332165598869324},{"id":"https://openalex.org/C2777607303","wikidata":"https://www.wikidata.org/wiki/Q641307","display_name":"Immunodeficiency","level":3,"score":0.4340072274208069},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4163703918457031},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33722615242004395},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29699045419692993},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.235319584608078},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.22876453399658203},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.36691/rja1563","doi":"https://doi.org/10.36691/rja1563","is_oa":false,"landing_page_url":"https://doi.org/10.36691/rja1563","pdf_url":null,"source":{"id":"https://openalex.org/S4210199164","display_name":"Russian Journal of Allergy","issn_l":"1810-8830","issn":["1810-8830","2686-682X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Russian Journal of Allergy","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1528075446","https://openalex.org/W1980766957","https://openalex.org/W2013487430","https://openalex.org/W2031607427","https://openalex.org/W2032091566","https://openalex.org/W2035351158","https://openalex.org/W2055354849","https://openalex.org/W2084885555","https://openalex.org/W2097901958","https://openalex.org/W2106152381","https://openalex.org/W2153972688","https://openalex.org/W2162495623","https://openalex.org/W2319918722","https://openalex.org/W2567983378","https://openalex.org/W2767813662","https://openalex.org/W2896389885","https://openalex.org/W2965880712","https://openalex.org/W3108824449","https://openalex.org/W3133505380","https://openalex.org/W4200126432","https://openalex.org/W4210351506"],"related_works":["https://openalex.org/W2031607427","https://openalex.org/W4392856634","https://openalex.org/W1981193620","https://openalex.org/W2319918722","https://openalex.org/W4395672617","https://openalex.org/W3080452552","https://openalex.org/W4402014406","https://openalex.org/W7135075140","https://openalex.org/W2127179351","https://openalex.org/W4205861475"],"abstract_inverted_index":{"Adverse":[0],"drug":[1,65,70,87,105,131,158],"reactions":[2],"are":[3],"one":[4,157],"of":[5,16,27,34,45,53,86,93,125,129,138,155],"the":[6,14,43,46,51,73,90,99,136,153,175],"most":[7],"complex":[8],"and":[9,18,50,57,89,95,111,135],"difficult":[10],"diagnostic":[11,100],"problems":[12],"in":[13,48,143],"practice":[15],"allergists":[17],"clinical":[19,25],"immunologists.":[20],"This":[21],"article":[22],"presents":[23],"a":[24,28,112,119,165],"case":[26],"patient":[29,61,145,166],"with":[30,42,77,167],"an":[31,63],"inborn":[32],"error":[33],"immunity,":[35],"known":[36],"as":[37],"common":[38],"variable":[39],"immune":[40,58],"deficiency":[41],"onset":[44],"disease":[47],"adulthood":[49],"presence":[52],"numerous":[54],"infectious,":[55],"structural,":[56],"complications.":[59],"The":[60,127],"had":[62],"adverse":[64],"reaction":[66],"represented":[67],"by":[68],"fixed":[69,130],"eruption":[71,132],"to":[72,133,140,174],"vital":[74],"antibiotic":[75],"therapy":[76],"ceftriaxone.":[78],"We":[79],"provide":[80],"detailed":[81],"information":[82],"about":[83],"this":[84,123,144],"type":[85,124],"allergy":[88,106],"structural":[91],"features":[92],"cephalosporins":[94,142],"their":[96],"cross-reactivity.":[97],"In":[98],"process,":[101],"we":[102],"ran":[103],"phased":[104],"testing,":[107],"including":[108],"patch":[109],"tests":[110],"dose":[113],"provocative":[114],"test,":[115],"which":[116,160],"is":[117,161],"considered":[118],"gold":[120],"standard":[121],"for":[122,164],"diagnostics.":[126],"diagnosis":[128],"ceftriaxone":[134],"absence":[137],"cross-reactivity":[139],"other":[141],"were":[146],"confirmed":[147],"based":[148],"on":[149],"test":[150],"results.":[151],"Prohibiting":[152],"use":[154],"only":[156],"(ceftriaxone),":[159],"especially":[162],"important":[163],"primary":[168],"immunodeficiency":[169],"was":[170],"made":[171],"possible":[172],"due":[173],"compiled":[176],"individual":[177],"recommendations.":[178]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4296136972","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2022-09-17T00:00:00"}
